Antiatherogenic and Cardioprotective Effects of a Xanthine Derivative KMUP‐1 in ApoE Knockout Mice
Cardiovascular Therapeutics · 2025
DOI: 10.1155/cdr/8419343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2025. Verfasst von Erna Sulistyowati und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Faculty of Medicine, Universitas Islam Malang, Malang, East Java, Indonesia. Hauptthemen laut MEDLINE: Atherosclerosis, Apolipoproteins E, Aorta, Aortic Diseases. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Direktorat Riset Dan Pengabdian Kepada Masyarakat, Chi Mei Medical Center, Kaohsiung Medical University.
Abstract (Originalsprache)
It is essential to manage cardiovascular disease related to atherosclerosis through understanding its disease progression mechanism. The effects of the xanthine derivative KMUP‐1 on alleviating atherosclerosis and cardiac remodeling, as well as its underlying mechanisms, were examined. In this study, atherosclerosis and cardiac damage were induced in ApoE knockout (KO) mice by feeding them a high‐fat diet (HFD) for 12 weeks. The co‐ and posttreatment of KMUP‐1 was evaluated. Our results showed that KMUP‐1 treatment significantly reduced body weight gain in HFD‐induced mice. The Oil Red O and hematoxylin–eosin staining showed that KMUP‐1 reduced the aortic plaque area, intima–media thickness, and intima–lumen thickness. KMUP‐1 reduced inflammatory cytokines IL‐1 β , TNF‐ α , IL‐6, and MCP‐1 in the serum of mice through an ELISA assay. Moreover, echocardiography evaluation indicated that KMUP‐1 attenuated left ventricular cardiac hypertrophy and restored cardiac function. Further, KMUP‐1 treatment suppressed proapoptotic protein Bax and reversed Bcl‐2 level by promoting autophagy‐related Gene 7 and autophagosome marker LC3‐II activation in the vascular through immunofluorescence and western blotting assay. KMUP‐1 improved the serum lipidomic profile. Both co‐ and posttreatment of KMUP‐1 stimulated autophagy and reduced inflammation and apoptosis, against atherosclerosis and cardiac remodeling in an ApoE‐KO mouse model. It suggests its potential as a therapeutic agent for cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Faculty of Medicine, Universitas Islam Malang, Malang, East Java, Indonesia.
- Department of Pharmacology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
- Department of Surgery, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Public Health, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.
ORCID-Profile: Shang-En Huang, Bin-Nan Wu, Ming-Chung Lin, Jwu-Lai Yeh
Förderung
- Direktorat Riset Dan Pengabdian Kepada Masyarakat
- Chi Mei Medical Center
- Kaohsiung Medical University
- National Science and Technology Council
Zitieren
APA
Sulistyowati, E., Huang, S. E., Hsu, C. C., Wu, Y. C., Chao, Y. Y., Hsu, J. H., Wu, B. N., Dai, Z. K., Lin, M. C., & Yeh, J. L. (2025). Antiatherogenic and Cardioprotective Effects of a Xanthine Derivative KMUP‐1 in ApoE Knockout Mice. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/8419343
Vancouver
Sulistyowati E, Huang SE, Hsu CC, Wu YC, Chao YY, Hsu JH, et al. Antiatherogenic and Cardioprotective Effects of a Xanthine Derivative KMUP‐1 in ApoE Knockout Mice. Cardiovascular Therapeutics. 2025. doi:10.1155/cdr/8419343
BibTeX
@article{Sulistyowati2025,
author = {Sulistyowati, Erna and Huang, Shang-En and Hsu, Chih-Chieh and Wu, Yi-Chia and Chao, Yu-Ying and Hsu, Jong-Hau and Wu, Bin-Nan and Dai, Zen-Kong and Lin, Ming-Chung and Yeh, Jwu-Lai},
title = {Antiatherogenic and Cardioprotective Effects of a Xanthine Derivative KMUP‐1 in ApoE Knockout Mice},
journal = {Cardiovascular Therapeutics},
year = {2025},
doi = {10.1155/cdr/8419343}
}
EUVIMED